# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-102826
Filing Date
2021-08-10
Accepted
2021-08-10 16:02:04
Documents
65
Period of Report
2021-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | mrkr-20210630x10q.htm iXBRL | 10-Q | 1228403
2 | EXHIBIT 31.1 | mrkr-20210630xex31d1.htm | EX-31.1 | 15083
3 | EXHIBIT 31.2 | mrkr-20210630xex31d2.htm | EX-31.2 | 15075
4 | EXHIBIT 32.1 | mrkr-20210630xex32d1.htm | EX-32.1 | 7497
5 | EXHIBIT 32.2 | mrkr-20210630xex32d2.htm | EX-32.2 | 8101
11 | GRAPHIC | mrkr-20210630x10q001.jpg | GRAPHIC | 6534
12 | GRAPHIC | mrkr-20210630x10q002.jpg | GRAPHIC | 19268
| Complete submission text file | 0001104659-21-102826.txt |  | 4716309

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | mrkr-20210630_lab.xml | EX-101.LAB | 262281
7 | XBRL TAXONOMY EXTENSION SCHEMA | mrkr-20210630.xsd | EX-101.SCH | 35497
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | mrkr-20210630_pre.xml | EX-101.PRE | 210174
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | mrkr-20210630_cal.xml | EX-101.CAL | 35829
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | mrkr-20210630_def.xml | EX-101.DEF | 78021
13 | EXTRACTED XBRL INSTANCE DOCUMENT | mrkr-20210630x10q_htm.xml | XML | 810410

Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 211159816
SIC: 2834 Pharmaceutical Preparations